Greg Gorgas, President & CEO of Artelo Biosciences, was recently a guest on Benzinga's All-Access.
Artelo is a clinical-stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the endocannabinoid system.
Artelo has a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, pain, neuropathy and inflammation.
